113 related articles for article (PubMed ID: 29172800)
1. The acceptability and effectiveness of a questionnaire for the identification of risk factors for HIV and hepatitis B and C: An observational study in general practice.
Aïm-Eusébi A; Prothon E; Majerholc C; Barger D; Yazdanpanah Y; Aubert JP
Eur J Gen Pract; 2018 Dec; 24(1):60-67. PubMed ID: 29172800
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices.
Ramsey SD; Unger JM; Baker LH; Little RF; Loomba R; Hwang JP; Chugh R; Konerman MA; Arnold K; Menter AR; Thomas E; Michels RM; Jorgensen CW; Burton GV; Bhadkamkar NA; Hershman DL
JAMA Oncol; 2019 Apr; 5(4):497-505. PubMed ID: 30653226
[TBL] [Abstract][Full Text] [Related]
3. 2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.
Bottero J; Brouard C; Roudot-Thoraval F; Deuffic-Burban S; Hofliger P; Abergel A; Volant J; Dhumeaux D; Yazdanpanah Y;
Liver Int; 2016 Oct; 36(10):1442-9. PubMed ID: 27043826
[TBL] [Abstract][Full Text] [Related]
4. Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign.
Orkin C; Flanagan S; Wallis E; Ireland G; Dhairyawan R; Fox J; Nandwani R; O'Connell R; Lascar M; Bulman J; Reeves I; Palfreeman A; Foster GR; Ahmad K; Anderson J; Tong CY; Lattimore S
HIV Med; 2016 Mar; 17(3):222-30. PubMed ID: 26919291
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
7. Development of a risk prediction score for screening for HBV, HCV and HIV among migrants in France: results from a multicentre observational study (STRADA study).
Duracinsky M; Yaya I; Yombo-Kokule L; Bessonneau P; Thonon F; Rousset-Torrente O; Roudot-Thoraval F; Lert F; Zucman D; Chassany O
BMJ Open; 2024 Jun; 14(6):e075315. PubMed ID: 38839381
[TBL] [Abstract][Full Text] [Related]
8. Viral hepatitis prevalence in patients with active and latent tuberculosis.
Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
[TBL] [Abstract][Full Text] [Related]
9. Routine screening for HIV, hepatitis B virus and hepatitis C virus in individuals undergoing oral and maxillofacial surgery.
Assoumou L; Thormann F; Soulié C; Caby F; Dudoit Y; Marcelin AG; Goudot P; Blanc C; Coriat P; Katlama C; Costagliola D; Pourcher V
HIV Med; 2019 May; 20(5):353-358. PubMed ID: 30924598
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
El-Hazmi MM
Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
[TBL] [Abstract][Full Text] [Related]
12. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia.
Al-Mughales JA
J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
Wolffram I; Petroff D; Bätz O; Jedrysiak K; Kramer J; Tenckhoff H; Berg T; Wiegand J;
J Hepatol; 2015 Jun; 62(6):1256-64. PubMed ID: 25617500
[TBL] [Abstract][Full Text] [Related]
14. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.
Mohamed HI; Saad ZM; Abd-Elreheem EM; Abd-ElGhany WM; Mohamed MS; Abd Elnaeem EA; Seedhom AE
J Infect Public Health; 2013 Jun; 6(3):186-95. PubMed ID: 23668463
[TBL] [Abstract][Full Text] [Related]
16. Prevalence estimates of HIV, syphilis, hepatitis B and C among female sex workers (FSW) in Brazil, 2016.
Ferreira-Júnior ODC; Guimarães MDC; Damacena GN; de Almeida WDS; de Souza-Júnior PRB; Szwarcwald CL;
Medicine (Baltimore); 2018 May; 97(1S Suppl 1):S3-S8. PubMed ID: 29912817
[TBL] [Abstract][Full Text] [Related]
17. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
18. [Proposal of HIV, HBV and HCV targeted screening: short period feasibility study in a free-access outpatient medical structure].
Aparicio C; Mourez T; Simoneau G; Magnier JD; Galichon B; Plaisance P; Bergmann JF; Sellier P
Presse Med; 2012 Oct; 41(10):e517-23. PubMed ID: 22464893
[TBL] [Abstract][Full Text] [Related]
19. [Seroprevalence of viral markers among blood donors at the Blood Donor Center of Mohammed V Military Teaching Hospital of Rabat, Morocco].
Uwingabiye J; Zahid H; Unyendje L; Hadef R
Pan Afr Med J; 2016; 25():185. PubMed ID: 28292147
[TBL] [Abstract][Full Text] [Related]
20. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
Guadagnino V; Zimatore G; Izzi A; Caroleo B; Rocca A; Montesano F; Costa C; Masciari R; Naso E; Biselli R
J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
